Clincosm LogoSign in Get a demo

small cell lung cancer (sclc)

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

Small Cell Lung Cancer, SCLC Trial in Worldwide (Pembrolizumab, Normal saline solution, Carboplatin)

Completed
Has Results
  • Small Cell Lung Cancer (SCLC)
  • Pembrolizumab
  • +4 more
  • Miami, Florida
  • +147 more
Sep 2, 2022

Small Cell Lung Cancer (SCLC) Trial in Guangzhou (Anlotinib Tislelizumab Irinotecan)

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • Anlotinib Tislelizumab Irinotecan
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Traditional Chinese Medicine
Jun 30, 2022

Spanish Real World Data on Patients Treated With Durvalumab

Completed
  • Small Cell Lung Cancer (SCLC)
  • Santiago De Compostela, A Coruña, Spain
  • +38 more
Jun 2, 2022

Small Cell Lung Cancer (SCLC) Trial in France, Italy, United Kingdom (Pembrolizumab, cis/carboplatin and etoposide)

Active, not recruiting
  • Small Cell Lung Cancer (SCLC)
  • Avignon, France
  • +18 more
May 9, 2022

Small Cell Lung Cancer (SCLC) Trial in Beijing (JK-1201I)

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Dec 14, 2021

Small Cell Lung Cancer (SCLC) Trial in New York (biological, drug, radiation)

Terminated
Has Results
  • Small Cell Lung Cancer (SCLC)
  • Pembrolizumab
  • +4 more
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center at NYU Langone
Oct 18, 2021

Small Cell Lung Cancer (SCLC) Trial in Iowa City (Nab-paclitaxel, Gemcitabine)

Active, not recruiting
  • Small Cell Lung Cancer (SCLC)
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Jun 4, 2021

Small Cell Lung Cancer (SCLC) Trial (irinotecan liposome injection)

Unknown status
  • Small Cell Lung Cancer (SCLC)
  • irinotecan liposome injection
  • (no location specified)
Jan 26, 2021

Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and

Completed
  • Cervical Cancer
  • +16 more
  • INCAGN02385
  • Los Angeles, California
  • +3 more
Oct 28, 2020

Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC)

Completed
  • Non Small Cell Lung Cancer Squamous (NSCLC-Sq)
  • +5 more
  • Huntersville, North Carolina
  • +2 more
Dec 27, 2019

Small Cell Lung Cancer (SCLC), Neuroendocrine (NE) Tumors, Large Cell Neuroendocrine (NE) Tumors Trial in Baltimore (Rhenium Re

Withdrawn
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Rhenium Re 188-P2045
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Oct 15, 2019

Breast Cancer, NSCLC, Ovary Cancer Trial in Bellinzona (PF-05212384, Paclitaxel, Carboplatin)

Completed
  • Breast Cancer
  • +5 more
  • Bellinzona, TI, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
May 20, 2019

Small Cell Lung Cancer (SCLC), Neuroendocrine Tumors Trial in Stanford (Desipramine HCL)

Terminated
Has Results
  • Small Cell Lung Cancer (SCLC)
  • Neuroendocrine Tumors
  • Desipramine HCL
  • Stanford, California
    Stanford University Cancer Institute
Mar 2, 2017

Small Cell Lung Cancer (SCLC) Trial in Germany, Italy, Japan (TAS-102, Amrubicin (Japan), Topotecan (Japan/Europe))

Terminated
  • Small Cell Lung Cancer (SCLC)
  • Mannheim, Baden-Württemberg, Germany
  • +22 more
Jul 11, 2014

Small Cell Lung Cancer (SCLC) Trial ([18F]HX4)

Withdrawn
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Aug 26, 2013